In vitro pharmacodynamics of nemonoxacin and other antimicrobial agents against Mycoplasma pneumoniae

Na Wang,Yuancheng Chen,Xingyi Qu,Xingchen Bian,Jiali Hu,Xiaogang Xu,Li Xiao,Yang Liu,Jing Zhang
DOI: https://doi.org/10.1128/spectrum.02431-23
2023-12-12
Abstract:This study first reported the in vitro effector kinetics of the new non-fluorinated quinolone, nemonoxacin, against macrolide-resistant M. pneumoniae (MRMP) and macrolide susceptible M. pneumoniae (MSMP) strains along with other antimicrobial agents. The time-kill assays and pharmacodynamic analysis showed that nemonoxacin has significant mycoplasmacidal activity against MRMP and MSMP. This study paves the road to establish appropriate dosing protocols of a new antimicrobial drug for children infected with M. pneumoniae.
What problem does this paper attempt to address?